Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudi Peché

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Clinical Medicine|December 10, 2021
Matching the Inhaler to the Patient in COPDRudi Peché, Darush Attar-Zadeh, Jane Scullion, et al.
Cureus|September 12, 2025
Respiratory Involvement During the Course of Hypocomplementemic Urticarial Vasculitis: A Case ReportLeroy Dorian, Rudi Peché, Julien Guiot, et al.
The European Respiratory Journal|August 4, 2018
Launching Global Lung Function Initiative reference values in Belgium: tips and tricksEric Derom, Giuseppe Liistro, Ellie Oostveen, et al.
Respiratory Medicine|February 24, 2012
Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking statusGuy Brusselle, Rudi Peché, Paul Van den Brande, et al.
Current Medical Research and Opinion|June 23, 2005
Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot studyLieven Dupont, Emmanuel Potvin, Dana Korn, et al.
Current Medical Research and Opinion|February 6, 2009
Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label studyDana Korn, Paul Van den Brande, Emmanuel Potvin, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 14, 2020
Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathwaysDidier Cataldo, Renaud Louis, Alain Michils, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 20, 2021
Towards Rational Prescription of Common Inhaler Medication in the Multimorbid COPD PatientIoanna Tsiligianni, Kristian Jong Hoeines, Christian Jensen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 18, 2018
Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practiceDidier Cataldo, Eric Derom, Giuseppe Liistro, et al.
Respiratory Medicine|October 7, 2015
New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferencesVincent Ninane, Jan Vandevoorde, Didier Cataldo, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Clinical Medicine|December 10, 2021
Matching the Inhaler to the Patient in COPDRudi Peché, Darush Attar-Zadeh, Jane Scullion, et al.
Cureus|September 12, 2025
Respiratory Involvement During the Course of Hypocomplementemic Urticarial Vasculitis: A Case ReportLeroy Dorian, Rudi Peché, Julien Guiot, et al.
The European Respiratory Journal|August 4, 2018
Launching Global Lung Function Initiative reference values in Belgium: tips and tricksEric Derom, Giuseppe Liistro, Ellie Oostveen, et al.
Respiratory Medicine|February 24, 2012
Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking statusGuy Brusselle, Rudi Peché, Paul Van den Brande, et al.
Current Medical Research and Opinion|June 23, 2005
Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot studyLieven Dupont, Emmanuel Potvin, Dana Korn, et al.
Current Medical Research and Opinion|February 6, 2009
Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label studyDana Korn, Paul Van den Brande, Emmanuel Potvin, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 14, 2020
Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathwaysDidier Cataldo, Renaud Louis, Alain Michils, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 20, 2021
Towards Rational Prescription of Common Inhaler Medication in the Multimorbid COPD PatientIoanna Tsiligianni, Kristian Jong Hoeines, Christian Jensen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 18, 2018
Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practiceDidier Cataldo, Eric Derom, Giuseppe Liistro, et al.
Respiratory Medicine|October 7, 2015
New developments in inhaler devices within pharmaceutical companies: A systematic review of the impact on clinical outcomes and patient preferencesVincent Ninane, Jan Vandevoorde, Didier Cataldo, et al.
Pageof 2